May 27, 2020
Pregnancy reprograms breast cells, reducing cancer risk
May 19, 2020
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy(TM) (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
May 13, 2020
Age-Related Macular Degeneration Markets, Pipeline, Drugs and Companies: 2016-2024
May 07, 2020
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
May 04, 2020
The Pandemics within the Pandemic
Apr 27, 2020
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
Apr 23, 2020
Elysium Health(TM) Announces Exclusive License of DNA Methylation Biomarkers of Personalized Health and Aging and Cellular Senescence from Yale University
Apr 13, 2020
Toxic Cell Atlas Guides New Therapies for Neurodegeneration
Mar 30, 2020
Global Juvenile Macular Degeneration (Stargardt Disease) Pipeline Guide 2020 - Therapeutics Development & Assessment, Companies Involved, Drug Profiles, Dormant Projects, Discontinued Products
Mar 23, 2020
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Mar 16, 2020
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Mar 13, 2020
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Feb 17, 2020
Acuity Eye Group Encourages Eye Exams to Detect for Signs of Macular Degeneration during AMD Awareness Month
Feb 03, 2020
Age-related Macular Degeneration (AMD) Pipeline Insight Report 2020 - Analysis by Development Stage, Product Type, Route of Administration, Molecule Type, and MOA Type
Jan 14, 2020
MacuLogix Introduces the AdaptDx Pro, Guided by Theia
Jan 06, 2020
Eiger Updates on 2019 Progress and 2020 Milestones Expected
Dec 17, 2019
First-Ever Treatment for Rare, Rapid-Aging Disease Progeria Submitted in New Drug Application to the FDA
Dec 17, 2019
Mitotech and Essex Bio-Technology Announce Enrollment in VISTA-2 - a pivotal Phase 3 Clinical Study of SkQ1 for Dry Eye Disease
Dec 16, 2019
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Dec 06, 2019
Getting closer to victory over aging: IVAO company announces a new product